secwatch.observer — SEC 8-K summary
======================================

Issuer:     Telomir Pharmaceuticals, Inc. (TELO)
CIK:        0001971532
Form:       8-K
Filed at:   2025-11-20T23:59:59+00:00
Accession:  0001493152-25-024491
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Telomir Pharmaceuticals director Craig Eagle resigns from board, effective Nov 14, 2025
--------------------------------------------------------------------------------

- Craig Eagle resigned from the Board of Directors on November 14, 2025, effective immediately.
- Resignation was not due to any disagreement with the Company, management, or other board members.
- The Board thanked Mr. Eagle for his service; no successor has been announced.
- Resignation letter attached as Exhibit 17.1 to the 8-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1971532/000149315225024491/0001493152-25-024491-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1971532/000149315225024491/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-024491

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer